about
Integrating HIV care into nurse-led primary health care services in South Africa: a synthesis of three linked qualitative studiesIs the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study.A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reductionImpact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-AnalysisAn ethnographic exploration of drug markets in Kisumu, KenyaThe experience of initiating injection drug use and its social context: A qualitative systematic review and thematic synthesis.Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.Towards "evidence-making intervention" approaches in the social science of implementation science: The making of methadone in East Africa.'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.Editorial commentary: successful methadone delivery in East Africa and its global implications.Next generation of comprehensive HIV prevention.A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA."They accept me, because I was one of them": formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal.A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK.Integrated and differentiated methadone and HIV care for people who use drugs: a qualitative study in Kenya with implications for implementation science"Another Person Was Going to Do It": The Provision of Injection Drug Use Initiation Assistance in a High-Risk U.S.-Mexico Border Region
P50
Q34707719-D2D816C0-E2BD-4C2A-8247-3B98A70D805CQ35179898-5541D37B-406D-4441-B677-E984C460685DQ36023600-C86928AD-2437-4748-A336-D5845EB6EE39Q36061620-F89C8749-6920-4F29-9153-E67FAB2658C7Q36837365-841C44DA-6F58-473F-BBED-E1478BBE43E8Q38666883-11A211DF-1530-477F-A5AC-FAFB9DF0AA13Q38747691-8C7550C9-4968-45DA-ADD3-E11C1D42B3CAQ39395669-22E1CA92-EF34-48E5-B615-CC77E5D1EA5AQ42104687-C9EFEE42-F865-4610-A0D9-033C4AD50EC5Q43833038-C8283E21-BFB6-4813-A3EA-408A74C44D2BQ46024815-2627A185-AA4A-4A18-9F0D-0E3CA938CCABQ51741856-D3715772-E6F8-4F9D-A976-57D77A679586Q51746853-9A758469-85E5-43EF-A91A-E8497D381DE9Q55340444-1528BAF7-B6B7-4FE6-B80C-340A103FCDC7Q91789329-9E0DA73D-9BF4-4A42-A440-1486A4A6F552Q92468547-F3070451-F26F-4C84-BD5E-189C8EC5D00A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andy Guise
@ast
Andy Guise
@en
Andy Guise
@es
Andy Guise
@nl
Andy Guise
@sl
type
label
Andy Guise
@ast
Andy Guise
@en
Andy Guise
@es
Andy Guise
@nl
Andy Guise
@sl
altLabel
Andy
@en
prefLabel
Andy Guise
@ast
Andy Guise
@en
Andy Guise
@es
Andy Guise
@nl
Andy Guise
@sl
P106
P1153
26324906200
P2038
Andy_Guise
P21
P31
P496
0000-0002-0981-4663